Bone Pain
8
5
5
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
25.0%
2 terminated out of 8 trials
0.0%
-86.6% vs benchmark
0%
0 trials in Phase 3/4
0%
1 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (8)
Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF
Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
Correlation of Timing of Pegfilgrastim Administration and PIBP.
Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use